Skip to main content
Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · IEX Real-Time Price · USD
0.830
+0.010 (1.23%)
At close: May 17, 2024, 4:00 PM
0.840
+0.010 (1.19%)
After-hours: May 17, 2024, 6:01 PM EDT

Rapid Micro Biosystems Revenue

Rapid Micro Biosystems had revenue of $23.10M in the twelve months ending March 31, 2024, with 28.25% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $5.61M with 11.44% year-over-year growth. In the year 2023, Rapid Micro Biosystems had annual revenue of $22.52M with 31.44% growth.

Revenue (ttm)
$23.10M
Revenue Growth
+28.25%
P/S Ratio
1.55
Revenue / Employee
$119,663
Employees
193
Market Cap
35.90M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202322.52M5.39M31.44%
Dec 31, 202217.13M-6.10M-26.25%
Dec 31, 202123.23M7.16M44.50%
Dec 31, 202016.08M-435.00K-2.63%
Dec 31, 201916.51M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nutex Health 258.77M
Fortress Biotech 85.11M
Owlet 58.02M
ImmuCell 21.28M
Marker Therapeutics 3.32M
IGC Pharma 1.22M
Revenue Rankings

RPID News

More News